Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.070
-0.010 (-0.93%)
At close: Apr 28, 2026, 4:00 PM EDT
1.060
-0.010 (-0.93%)
After-hours: Apr 28, 2026, 6:26 PM EDT
Company Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States.
The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients.
Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Arcadia Biosciences, Inc.
| Country | United States |
| Founded | 2002 |
| IPO Date | May 15, 2015 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 8 |
| CEO | Thomas Schaefer |
Contact Details
Address: 5950 Sherry Lane, Suite 215 Dallas, Texas 75225 United States | |
| Phone | 214 974 8921 |
| Website | arcadiabio.com |
Stock Details
| Ticker Symbol | RKDA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001469443 |
| CUSIP Number | 039014204 |
| ISIN Number | US0390143032 |
| Employer ID | 81-0571538 |
| SIC Code | 1311 |
Key Executives
| Name | Position |
|---|---|
| Thomas J. Schaefer C.F.A. | Chief Executive Officer, Interim Chief Financial Officer, Principal Accounting Officer, President, Corporate Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2026 | 8-K | Current Report |
| Mar 26, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Feb 11, 2026 | 424B3 | Prospectus |
| Feb 10, 2026 | EFFECT | Notice of Effectiveness |
| Feb 6, 2026 | 8-K | Current Report |
| Jan 28, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Jan 27, 2026 | D | Notice of Exempt Offering of Securities |
| Jan 20, 2026 | RW | Filing |
| Jan 14, 2026 | 8-K | Current Report |